| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6462063
[patent_doc_number] => 20020178462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'PRENATAL SCREENING'
[patent_app_type] => new
[patent_app_number] => 09/226766
[patent_app_country] => US
[patent_app_date] => 1999-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25058
[patent_no_of_claims] => 86
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20020178462.pdf
[firstpage_image] =>[orig_patent_app_number] => 09226766
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/226766 | Nuclear reprogramming using cytoplasmic extract | Jan 5, 1999 | Issued |
| 09/225233 | QUIESCENT CELL POPULATIONS FOR NUCLEAR TRANFER | Jan 3, 1999 | Abandoned |
Array
(
[id] => 4275038
[patent_doc_number] => 06245964
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Transgenic rodent comprising APP-Swedish'
[patent_app_type] => 1
[patent_app_number] => 9/209647
[patent_app_country] => US
[patent_app_date] => 1998-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 15773
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245964.pdf
[firstpage_image] =>[orig_patent_app_number] => 209647
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/209647 | Transgenic rodent comprising APP-Swedish | Dec 9, 1998 | Issued |
Array
(
[id] => 4299598
[patent_doc_number] => 06325998
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Methods of treating disease using recombinant adeno-associated virus virions administered to muscle'
[patent_app_type] => 1
[patent_app_number] => 9/205337
[patent_app_country] => US
[patent_app_date] => 1998-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18026
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/325/06325998.pdf
[firstpage_image] =>[orig_patent_app_number] => 205337
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/205337 | Methods of treating disease using recombinant adeno-associated virus virions administered to muscle | Dec 3, 1998 | Issued |
Array
(
[id] => 6934241
[patent_doc_number] => 20010055585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'FRNK PROTEINS IN THE TREATMENT OF TUMOR CELLS'
[patent_app_type] => new
[patent_app_number] => 09/204134
[patent_app_country] => US
[patent_app_date] => 1998-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8125
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20010055585.pdf
[firstpage_image] =>[orig_patent_app_number] => 09204134
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/204134 | FRNK PROTEINS IN THE TREATMENT OF TUMOR CELLS | Dec 1, 1998 | Abandoned |
Array
(
[id] => 4263840
[patent_doc_number] => 06258998
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Method of cloning porcine animals'
[patent_app_type] => 1
[patent_app_number] => 9/199138
[patent_app_country] => US
[patent_app_date] => 1998-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 29705
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258998.pdf
[firstpage_image] =>[orig_patent_app_number] => 199138
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/199138 | Method of cloning porcine animals | Nov 23, 1998 | Issued |
Array
(
[id] => 1206520
[patent_doc_number] => 06717031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-04-06
[patent_title] => 'Method for selecting a transgenic mouse model of alzheimer\'s disease'
[patent_app_type] => B2
[patent_app_number] => 09/149718
[patent_app_country] => US
[patent_app_date] => 1998-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 37032
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/717/06717031.pdf
[firstpage_image] =>[orig_patent_app_number] => 09149718
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/149718 | Method for selecting a transgenic mouse model of alzheimer's disease | Sep 7, 1998 | Issued |
Array
(
[id] => 1508427
[patent_doc_number] => 06441145
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Transgenically produced Antithrombin III'
[patent_app_type] => B1
[patent_app_number] => 09/143155
[patent_app_country] => US
[patent_app_date] => 1998-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7143
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441145.pdf
[firstpage_image] =>[orig_patent_app_number] => 09143155
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/143155 | Transgenically produced Antithrombin III | Aug 27, 1998 | Issued |
| 09/139902 | DIRECT OVIDUCT TRANSGENESIS | Aug 24, 1998 | Abandoned |
Array
(
[id] => 4325040
[patent_doc_number] => 06331659
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Cumulus cells as nuclear donors'
[patent_app_type] => 1
[patent_app_number] => 9/132104
[patent_app_country] => US
[patent_app_date] => 1998-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11709
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331659.pdf
[firstpage_image] =>[orig_patent_app_number] => 132104
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/132104 | Cumulus cells as nuclear donors | Aug 9, 1998 | Issued |
Array
(
[id] => 1570906
[patent_doc_number] => 06498285
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Methods for producing transgenic pigs by microinjecting a blastomere'
[patent_app_type] => B1
[patent_app_number] => 09/129395
[patent_app_country] => US
[patent_app_date] => 1998-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7816
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498285.pdf
[firstpage_image] =>[orig_patent_app_number] => 09129395
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/129395 | Methods for producing transgenic pigs by microinjecting a blastomere | Aug 4, 1998 | Issued |
Array
(
[id] => 4292231
[patent_doc_number] => 06211429
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Complete oocyte activation using an oocyte-modifying agent and a reducing agent'
[patent_app_type] => 1
[patent_app_number] => 9/100167
[patent_app_country] => US
[patent_app_date] => 1998-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 11410
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211429.pdf
[firstpage_image] =>[orig_patent_app_number] => 100167
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/100167 | Complete oocyte activation using an oocyte-modifying agent and a reducing agent | Jun 17, 1998 | Issued |
Array
(
[id] => 6638753
[patent_doc_number] => 20020016978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'TRANSGENIC ANIMAL EXPRESSING NON-NATIVE WILD-TYPE AND FAMILIAL ALZHEIMER\'S DISEASE MUTANT PRESENILIN 1 PROTEIN ON NATIVE PRESENILIN 1 NULL BACKGROUND'
[patent_app_type] => new
[patent_app_number] => 09/078871
[patent_app_country] => US
[patent_app_date] => 1998-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11322
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016978.pdf
[firstpage_image] =>[orig_patent_app_number] => 09078871
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/078871 | Transgenic mouse expressing non-native wild-type and familial Alzheimer's Disease mutant presenilin 1 protein on native presenilin 1 null background | May 13, 1998 | Issued |
Array
(
[id] => 4338479
[patent_doc_number] => 06284239
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Murine model for human carcinoma'
[patent_app_type] => 1
[patent_app_number] => 9/078207
[patent_app_country] => US
[patent_app_date] => 1998-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6563
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284239.pdf
[firstpage_image] =>[orig_patent_app_number] => 078207
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/078207 | Murine model for human carcinoma | May 12, 1998 | Issued |
Array
(
[id] => 5887913
[patent_doc_number] => 20020012655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'CLONED UNGULATE EMBRYOS AND ANIMALS, USE OF CELLS, TISSUES AND ORGANS THEREOF FOR TRANSPLANTATION THERAPIES INCLUDING PARKINSON\'S DISEASE'
[patent_app_type] => new
[patent_app_number] => 09/066652
[patent_app_country] => US
[patent_app_date] => 1998-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22104
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20020012655.pdf
[firstpage_image] =>[orig_patent_app_number] => 09066652
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/066652 | CLONED UNGULATE EMBRYOS AND ANIMALS, USE OF CELLS, TISSUES AND ORGANS THEREOF FOR TRANSPLANTATION THERAPIES INCLUDING PARKINSON'S DISEASE | Apr 26, 1998 | Abandoned |
| 09/058384 | TEST AND MODEL FOR ALZHEIMER'S DISEASE | Apr 8, 1998 | Abandoned |
Array
(
[id] => 1290725
[patent_doc_number] => 06632976
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-14
[patent_title] => 'Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene'
[patent_app_type] => B1
[patent_app_number] => 09/033936
[patent_app_country] => US
[patent_app_date] => 1998-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 50
[patent_no_of_words] => 56379
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/632/06632976.pdf
[firstpage_image] =>[orig_patent_app_number] => 09033936
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/033936 | Chimeric mice that are produced by microcell mediated chromosome transfer and that retain a human antibody gene | Mar 1, 1998 | Issued |
Array
(
[id] => 4387921
[patent_doc_number] => 06262335
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Transgenic mice expressing APP mutant at amino acids 717, 721 and 722'
[patent_app_type] => 1
[patent_app_number] => 9/019973
[patent_app_country] => US
[patent_app_date] => 1998-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 10230
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262335.pdf
[firstpage_image] =>[orig_patent_app_number] => 019973
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/019973 | Transgenic mice expressing APP mutant at amino acids 717, 721 and 722 | Feb 5, 1998 | Issued |
Array
(
[id] => 4353444
[patent_doc_number] => 06215041
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Cloning using donor nuclei from a non-quiesecent somatic cells'
[patent_app_type] => 1
[patent_app_number] => 9/004606
[patent_app_country] => US
[patent_app_date] => 1998-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15446
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/215/06215041.pdf
[firstpage_image] =>[orig_patent_app_number] => 004606
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/004606 | Cloning using donor nuclei from a non-quiesecent somatic cells | Jan 7, 1998 | Issued |
| 08/993564 | CHIMERIC EMBRYOS AND ANIMALS CONTAINING HUMAN CELLS | Dec 17, 1997 | Abandoned |